UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 22,
Protagonist Therapeutics (NASDAQ:PTGX)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Protagonist Therapeutics
Protagonist Therapeutics (NASDAQ:PTGX)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Protagonist Therapeutics

Actualités Protagonist Therapeutics, Inc

Turnstone Biologics Appoints William Waddill to its Board of Directors
Mardi 16 Avril 2024 ( il y a 1 semaine) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Samedi 2 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Samedi 2 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Samedi 2 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Vendredi 1 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Jeudi 29 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 29 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 8-K - Current report
Mardi 27 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mercredi 14 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mercredi 14 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)
Form 8-K - Current report
Mercredi 31 Janvier 2024 ( il y a 3 mois) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 19 Janvier 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Plus d'articles sur Protagonist Therapeutics, Inc